Two codependent routes lead to high-level MRSA.

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant clinical threat due to its resistance to beta-lactam antibiotics.
• This resistance is primarily conferred by the mecA gene, encoding penicillin-binding protein 2a (PBP2a).

Purpose of the Study:

• To investigate the cellular and molecular mechanisms MRSA employs to maintain viability and division in the presence of antibiotics.
• To identify potential novel therapeutic targets by understanding MRSA's antibiotic resistance strategies.

Main Methods:

• Comparative analysis of MRSA cell division and peptidoglycan synthesis under antibiotic pressure.
• Genetic analysis of essential penicillin-binding proteins (PBPs) and identification of compensatory mutations.

Main Results:

• MRSA exhibits an alternative cell division mode and altered peptidoglycan architecture at the division septum when exposed to antibiotics.
• PBP2a can substitute for PBP2's transpeptidase activity but not PBP1's, which is crucial for native septal peptidoglycan.
• Chromosomal potentiator (pot) mutations enable MRSA division in the absence of PBP1 activity.

Conclusions:

• MRSA utilizes a dual mechanism involving PBP2a activity and an alternative division pathway for high-level antibiotic resistance.
• Targeting these interconnected resistance mechanisms presents a promising strategy for developing novel MRSA resensitizing agents.